4.4 Article

Severe Disease Activity and Cytomegalovirus Colitis Are Predictive of a Nonresponse to Infliximab in Patients with Ulcerative Colitis

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Cytomegalovirus Load in Inflamed Intestinal Tissue Is Predictive of Resistance to Immunosuppressive Therapy in Ulcerative Colitis

Xavier Roblin et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)

Article Genetics & Heredity

No association between TNFSF15 and IL23R with ulcerative colitis in Koreans

Suk-Kyun Yang et al.

JOURNAL OF HUMAN GENETICS (2011)

Article Gastroenterology & Hepatology

A Multicenter Experience With Infliximab for Ulcerative Colitis: Outcomes and Predictors of Response, Optimization, Colectomy, and Hospitalization

Abderrahim Oussalah et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)

Article Gastroenterology & Hepatology

Disease Activity, ANCA, and IL23R Genotype Status Determine Early Response to Infliximab in Patients With Ulcerative Colitis

Matthias Juergens et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)

Review Gastroenterology & Hepatology

Cytomegalovirus in Inflammatory Bowel Disease: Pathogen or Innocent Bystander?

Garrett Lawlor et al.

INFLAMMATORY BOWEL DISEASES (2010)

Review Gastroenterology & Hepatology

Distribution and Manifestations of Inflammatory Bowel Disease in Asians, Hispanics, and African Americans: A Systematic Review

Jason K. Hou et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)

Article Gastroenterology & Hepatology

Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study)

Inger Camilla Solberg et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)

Review Gastroenterology & Hepatology

An Update on the Epidemiology of Inflammatory Bowel Disease in Asia

Kelvin T. Thia et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)

Article Gastroenterology & Hepatology

Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: A KASID study

Suk-Kyun Yang et al.

INFLAMMATORY BOWEL DISEASES (2008)

Article Gastroenterology & Hepatology

Long-term outcome after infliximab for refractory ulcerative colitis

Marc Ferrante et al.

JOURNAL OF CROHNS & COLITIS (2008)

Article Gastroenterology & Hepatology

A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis

C. W. Lees et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)

Article Gastroenterology & Hepatology

Clinical features and natural history of ulcerative colitis in Korea

Sang Hyoung Park et al.

INFLAMMATORY BOWEL DISEASES (2007)

Article Gastroenterology & Hepatology

Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients

Katsuyoshi Matsuoka et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)

Article Gastroenterology & Hepatology

Predictors of early response to infliximab in patients with ulcerative colitis

Marc Ferrante et al.

INFLAMMATORY BOWEL DISEASES (2007)

Article Medicine, General & Internal

Infliximab for induction and maintenance therapy for ulcerative colitis

P Rutgeerts et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Medicine, General & Internal

Infliximab maintenance therapy for fistulizing Crohn's disease

BE Sands et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Review Medicine, General & Internal

Inflammatory bowel disease

DK Podolsky

NEW ENGLAND JOURNAL OF MEDICINE (2002)

Article Medicine, General & Internal

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

SB Hanauer et al.

LANCET (2002)

Article Gastroenterology & Hepatology

Incidence and prevalence of ulcerative colitis in the Songpa-Kangdong District, Seoul, Korea, 1986-1997

SK Yang et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2000)